Full Press Release Details
Product introductions and expert presentations offer thought leadership in drug delivery innovation and patient adherence to meet the challenges of pharmaceutical pipelines
EXTON, Pa. , Jan. 31, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced participation at Pharmapack Europe 2023 in Paris, France to showcase its leadership and expertise on industry challenges and trends in packaging and containment. The company expands its innovations for global customers and their patients with the introduction of three new products: West Ready Pack™ with Corning Valor® RTU Vials utilizing Stevanato Group's EZ-fill® SG EZ-fill® technology, Daikyo Crystal Zenith® 2.25mL Insert Needle Syringe System and FluroTec® 5-10mL Cartridge Plunger.
"This year, we are introducing three new product solutions at Pharmapack," said Li Chen , Vice President and General Manager, Biologics at West. "With these innovations, we are addressing the growing market needs for today's complex and sensitive molecules, including large-volume delivery and a complete vial containment solution that can protect and scale from development through commercialization."
West's participation in this year's conference includes:
For more information about West, please visit our website: www.westpharma.com
For more information about Pharmapack , please visit: Pharmapack Europe
About West West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With approximately 10,000 team members across 50 sites worldwide, West helps support our customers by delivering over 45 billion components and devices each year.
2023 marks West's 100-year milestone of innovation and the critical role it continues to play in healthcare and the patient experience. Headquartered in Exton, Pennsylvania , West in its fiscal year 2021 generated $2.83 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST ) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com .
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.
© 2023 West Pharmaceutical Services, Inc.
Ready Pack, Flip-Off, NovaPure, and FluroTec are trademarks or registered trademarks of West Pharmaceutical Services, Inc. in the United States and other jurisdictions.
FluroTec technology is licensed from Daikyo Seiko, Ltd.
Valor® is a registered trademark of Corning Incorporated.
EZ-fill is a registered trademark of Stevanato Group.
West Pharmaceutical Services, Inc. is the exclusive distributor of Corning Valor® Glass.
SOURCE West Pharmaceutical Services, Inc.